Targeting microfilaments in cancer therapy is of interest because of their pivotal role in cellular processes that are often hijacked by cancer cells. Cancerous cells exploit the dynamic nature of microfilaments to facilitate rapid and uncontrolled growth, invasion into surrounding tissues, and dissemination to distant sites, known as metastasis. By disrupting the function of microfilaments, it may be possible to impair these critical processes and effectively inhibit cancer progression.
